Caris Life Sciences Inc (CAI)

Currency in USD
28.00
-0.46(-1.62%)
Closed·
28.16+0.16(+0.57%)
·
CAI is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
27.8628.55
52 wk Range
22.8642.50
Key Statistics
Prev. Close
28.46
Open
28.35
Day's Range
27.86-28.55
52 wk Range
22.86-42.5
Volume
1.16M
Average Volume (3m)
1.63M
1-Year Change
-
Book Value / Share
1.7
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CAI Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
38.11
Upside
+36.11%
Members' Sentiments
Bearish
Bullish
ProTips
Liquid assets exceed short term obligations

Caris Life Sciences Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Neutral

Caris Life Sciences Company Profile

Caris Life Sciences, Inc., an artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally. It develops and commercializes solutions to transform healthcare using molecular information, and machine learning algorithms. The company’s molecular profiling services portfolio includes MI Profile, a tissue-based molecular profiling solution; and Caris Assure, a blood-based molecular profiling solution for cancer treatment. It also offers pharma research and development services comprising laboratory delivery, strategic data, and research services to biopharmaceutical customers. The company was founded in 2008 and is headquartered in Irving, Texas.

Compare CAI to Peers and Sector

Metrics to compare
CAI
Peers
Sector
Relationship
P/E Ratio
−11.6x−4.2x−0.6x
PEG Ratio
-−0.210.00
Price/Book
16.5x5.2x2.6x
Price / LTM Sales
12.2x10.1x3.2x
Upside (Analyst Target)
33.5%40.4%41.8%
Fair Value Upside
Unlock−13.2%5.1%Unlock

Analyst Ratings

8 Buy
1 Hold
0 Sell
Ratings:
9 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 38.11
(+36.11% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Canaccord Genuity
Buy30.00+7.14%28.00Maintain22/12/2025
Canaccord Genuity
Hold28.00--New Coverage02/12/2025
TD Cowen
Buy38.00+35.71%32.00Maintain13/08/2025
Guggenheim
Buy36.00+28.57%32.00Maintain13/08/2025
BofA Securities
Buy37.00+32.14%31.00Maintain13/08/2025

Earnings

Latest Release
Nov 05, 2025
EPS / Forecast
0.08 / --
Revenue / Forecast
216.80M / --
EPS Revisions
Last 90 days

People Also Watch

176.77
INSM
+0.57%
71.59
TTMI
+0.99%
171.99
PI
-3.51%
195.34
ORCL
-1.53%
67.72
FISV
-1.31%

FAQ

What Is the Caris Life Sciences (CAI) Share Price Today?

The live Caris Life Sciences share price today is 28.00

What Stock Exchange Does Caris Life Sciences (CAI) Trade On?

Caris Life Sciences is listed and trades on the Nasdaq Stock Exchange.

What Is the Ticker (Stock Symbol) for Caris Life Sciences?

The stock symbol (also called a 'ticker') for Caris Life Sciences is "CAI."

What Is the Current Caris Life Sciences Market Cap?

As of today, Caris Life Sciences market capitalisation is 7.90B.

What Is Caris Life Sciences's (CAI) Earnings Per Share (TTM)?

The Caris Life Sciences EPS is currently -6.48 (Trailing Twelve Months).

When Is the Next Caris Life Sciences Earnings Date?

Caris Life Sciences's next earnings report will be released on 25 Feb 2026.

Is CAI a Buy or Sell From a Technical Analyst Perspective?

Based on today's Caris Life Sciences moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Caris Life Sciences Stock Split?

Caris Life Sciences has split 0 times. (See the CAI stock split history page for full effective split date and price information.)

How Many Employees Does Caris Life Sciences Have?

Caris Life Sciences has 1769 employees.

What is the current trading status of Caris Life Sciences (CAI)?

As of 24 Dec 2025, Caris Life Sciences (CAI) is trading at a price of 28.00, with a previous close of 28.46. The stock has fluctuated within a day range of 27.86 to 28.55, while its 52-week range spans from 22.86 to 42.50.

What Is Caris Life Sciences (CAI) Price Target According to Analysts?

The average 12-month price target for Caris Life Sciences is USD38.11111, with a high estimate of USD45 and a low estimate of USD30. 8 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +36.11% Upside potential.

What Is the CAI Premarket Price?

CAI's last pre-market stock price is 28.36. The pre-market share volume is 820.00, and the stock has decreased by -0.10, or -0.35%.

What Is the CAI After Hours Price?

CAI's last after hours stock price is 28.16, the stock has decreased by 0.16, or 0.57%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.